Lori Lyons-Williams's Net Worth
$601 Thousand
Who is Lori Lyons-Williams?
Lori Lyons-Williams does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RAPT Therapeutics, Inc., Dermira, Inc., and FIVE PRIME THERAPEUTICS, INC..
SEC CIK
Lori Lyons-Williams's CIK is 0001693564
Past Insider Trading and Trends
2019 was Lori Lyons-Williams's most active year for acquiring shares with 5 total transactions. Lori Lyons-Williams's most active month to acquire stocks was the month of January. 2020 was Lori Lyons-Williams's most active year for disposing of shares, totalling 7 transactions. Lori Lyons-Williams's most active month to dispose stocks was the month of January. 2018 saw Lori Lyons-Williams paying a total of $1,800,937.50 for 135,443 shares, this is the most they've acquired in one year. In 2020 Lori Lyons-Williams cashed out on 305,529 shares for a total of $476,268.75, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RAPT Therapeutics, Inc. (RAPT) Snapshot price: $25.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermira, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.40K |
$18.75 | -$476,268.75 |
0
|
Feb 20
| |||
Form 4
| +6.75% | 1.61K |
$7.91 | -$12,513.62 | 25.4K |
Aug 15
| |||
Form 4
| +470.87% | 19.63K |
$10.50 | -$108,927.00 | 23.79K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +36.18% | 695 |
$9.58 | -$3,525.44 | 2.62K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Contineum Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||